Clare Preskey has over 15 years of experience in clinical research, with expertise in Clinical Operations and Project Management. As Executive Director of Clinical Operations at Quotient Sciences, she leads a team of over 40 professionals, overseeing the delivery of global Phase I and II clinical trials, including ADME, FIH, and bioequivalence studies.

Clare has also driven cross-functional process improvements and training initiatives focused on protocol review, eligibility, and inhaled drug delivery. 

She holds a B.Sc. degree in Physiology with First Class Honours from the University of Manchester.